$2.16 Billion is the total value of Deep Track Capital, LP's 55 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 53.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $154,962,500 | -11.8% | 1,250,000 | +4.2% | 7.17% | -0.5% |
| INSM | INSMED INC | $137,150,000 | +23.8% | 6,500,000 | 0.0% | 6.35% | +39.5% | |
| IONS | IONIS PHARMACEUTICALS INC | $116,281,851 | +14.8% | 2,834,069 | 0.0% | 5.38% | +29.4% | |
| TVTX | Buy | TRAVERE THERAPEUTICS INC | $113,203,200 | -18.1% | 7,370,000 | +19.9% | 5.24% | -7.7% |
| STRUCTURE THERAPEUTICS INCsponsored ads | $110,026,714 | +74.7% | 2,646,782 | 0.0% | 5.09% | +96.9% | ||
| IMVT | Sell | IMMUNOVANT INC | $102,842,630 | -10.8% | 5,421,330 | -27.1% | 4.76% | +0.5% |
| ITCI | Sell | INTRA-CELLULAR THERAPIES INC | $98,035,317 | +6.5% | 1,548,252 | -8.9% | 4.54% | +20.0% |
| ALKS | ALKERMES PLC | $93,900,000 | +11.0% | 3,000,000 | 0.0% | 4.35% | +25.2% | |
| SWTX | Buy | SPRINGWORKS THERAPEUTICS INC | $92,987,526 | +16.5% | 3,546,435 | +14.4% | 4.30% | +31.3% |
| DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $84,726,983 | +36.0% | 6,557,816 | +3.3% | 3.92% | +53.3% |
| GERN | Sell | GERON CORP | $77,588,801 | +33.1% | 24,170,966 | -10.0% | 3.59% | +50.0% |
| PLRX | Buy | PLIANT THERAPEUTICS INC | $73,386,000 | -19.4% | 4,050,000 | +18.3% | 3.40% | -9.1% |
| BCYC | BICYCLE THERAPEUTICS PLCsponsored ads | $71,942,028 | +20.0% | 2,819,045 | 0.0% | 3.33% | +35.2% | |
| VRNA | VERONA PHARMA PLCsponsored ads | $67,381,953 | +5.3% | 3,187,415 | 0.0% | 3.12% | +18.6% | |
| GH | New | GUARDANT HEALTH INC | $53,700,000 | – | 1,500,000 | +100.0% | 2.49% | – |
| FDMT | Buy | 4D MOLECULAR THERAPEUTICS IN | $50,200,393 | +28.2% | 2,778,107 | +21.9% | 2.32% | +44.5% |
| AGEN | AGENUS INC | $48,000,000 | +5.3% | 30,000,000 | 0.0% | 2.22% | +18.6% | |
| BEAM | Buy | BEAM THERAPEUTICS INC | $42,061,900 | +9.9% | 1,317,316 | +5.4% | 1.95% | +23.9% |
| AUTL | AUTOLUS THERAPEUTICS PLCspon ads | $35,700,000 | +29.3% | 15,000,000 | 0.0% | 1.65% | +45.8% | |
| NTLA | Buy | INTELLIA THERAPEUTICS INC | $34,069,488 | +29.7% | 835,446 | +18.6% | 1.58% | +46.3% |
| VRDN | Buy | VIRIDIAN THERAPEUTICS INC | $30,439,353 | -2.7% | 1,279,502 | +4.0% | 1.41% | +9.6% |
| NRIX | NURIX THERAPEUTICS INC | $29,948,322 | +12.5% | 2,997,830 | 0.0% | 1.39% | +26.8% | |
| RPTX | REPARE THERAPEUTICS INC | $28,858,071 | +7.5% | 2,727,606 | 0.0% | 1.34% | +21.2% | |
| EDIT | New | EDITAS MEDICINE INC | $28,424,313 | – | 3,453,744 | +100.0% | 1.32% | – |
| DYN | Buy | DYNE THERAPEUTICS INC | $28,124,010 | +4.6% | 2,499,912 | +7.1% | 1.30% | +17.8% |
| ANIP | New | ANI PHARMACEUTICALS INC | $27,669,750 | – | 514,021 | +100.0% | 1.28% | – |
| AXSM | New | AXSOME THERAPEUTICS INC | $27,608,612 | – | 384,200 | +100.0% | 1.28% | – |
| PNT | Buy | POINT BIOPHARMA GLOBAL INC | $25,200,979 | +47.8% | 2,781,565 | +18.6% | 1.17% | +66.7% |
| EWTX | Sell | EDGEWISE THERAPEUTICS INC | $21,312,500 | +4.1% | 2,750,000 | -10.4% | 0.99% | +17.4% |
| New | ZURA BIO LTD | $20,688,600 | – | 2,523,000 | +100.0% | 0.96% | – | |
| PACB | Sell | PACIFIC BIOSCIENCES CALIF IN | $19,300,973 | -52.4% | 1,451,201 | -58.6% | 0.89% | -46.4% |
| ABOS | Sell | ACUMEN PHARMACEUTICALS INC | $18,837,696 | +17.4% | 3,916,361 | -0.9% | 0.87% | +32.3% |
| RAPT | Buy | RAPT THERAPEUTICS INC | $18,785,291 | +79.2% | 1,004,561 | +75.9% | 0.87% | +101.9% |
| PRTA | New | PROTHENA CORP PLCput | $17,070,000 | – | 250,000 | +100.0% | 0.79% | – |
| Sell | VIGIL NEUROSCIENCE INC | $16,670,045 | -15.9% | 1,773,409 | -12.4% | 0.77% | -5.2% | |
| Sell | ASTRIA THERAPEUTICS INC | $14,139,467 | -41.5% | 1,697,415 | -6.6% | 0.66% | -34.0% | |
| NUVB | NUVATION BIO INC | $13,897,238 | +8.4% | 7,720,688 | 0.0% | 0.64% | +22.2% | |
| MORF | New | MORPHIC HLDG INC | $12,426,392 | – | 216,752 | +100.0% | 0.58% | – |
| SLN | SILENCE THERAPEUTICS PLCads | $10,733,690 | -11.3% | 1,951,580 | 0.0% | 0.50% | 0.0% | |
| ORTX | New | ORCHARD THERAPEUTICS PLCspon ads new | $10,637,101 | – | 2,041,670 | +100.0% | 0.49% | – |
| NKTR | Buy | NEKTAR THERAPEUTICS | $10,338,336 | +743.7% | 17,973,464 | +931.0% | 0.48% | +858.0% |
| TERN | New | TERNS PHARMACEUTICALS INC | $9,617,930 | – | 1,099,192 | +100.0% | 0.44% | – |
| ETNB | Sell | 89BIO INC | $9,533,745 | -65.2% | 503,100 | -72.0% | 0.44% | -60.8% |
| INZY | Sell | INOZYME PHARMA INC | $9,157,197 | -50.8% | 1,644,021 | -49.4% | 0.42% | -44.6% |
| ZNTL | New | ZENTALIS PHARMACEUTICALS INC | $8,471,463 | – | 300,300 | +100.0% | 0.39% | – |
| RLMD | RELMADA THERAPEUTICS INC | $6,981,032 | +8.8% | 2,837,818 | 0.0% | 0.32% | +22.8% | |
| GHRS | GH RESEARCH PLCordinary shares | $5,925,381 | +48.5% | 499,400 | 0.0% | 0.27% | +67.1% | |
| CMPS | New | COMPASS PATHWAYS PLCsponsored ads | $5,616,821 | – | 678,360 | +100.0% | 0.26% | – |
| New | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $5,530,950 | – | 108,450 | +100.0% | 0.26% | – | |
| IPSC | CENTURY THERAPEUTICS INC | $3,232,339 | -8.9% | 1,022,892 | 0.0% | 0.15% | +2.7% | |
| HRTX | Sell | HERON THERAPEUTICS INC | $2,420,577 | -50.4% | 2,086,704 | -35.5% | 0.11% | -44.3% |
| FGEN | New | FIBROGEN INCcall | $2,064,690 | – | 764,700 | +100.0% | 0.10% | – |
| ALLK | Sell | ALLAKOS INC | $995,288 | -93.8% | 228,277 | -93.6% | 0.05% | -93.0% |
| IMUX | Sell | IMMUNIC INC | $773,868 | -79.4% | 308,314 | -87.8% | 0.04% | -76.6% |
| New | MINK THERAPEUTICS INC | $682,221 | – | 324,867 | +100.0% | 0.03% | – | |
| ETNB | Exit | 89BIO INCput | $0 | – | -4,400 | -100.0% | -0.00% | – |
| IMGN | Exit | IMMUNOGEN INCput | $0 | – | -428,100 | -100.0% | -0.07% | – |
| Exit | 2SEVENTY BIO INC | $0 | – | -350,000 | -100.0% | -0.15% | – | |
| NKTX | Exit | NKARTA INC | $0 | – | -1,354,200 | -100.0% | -0.20% | – |
| Exit | ORCHARD THERAPEUTICS PLCspon ads new | $0 | – | -1,166,670 | -100.0% | -0.26% | – | |
| JNCE | Exit | JOUNCE THERAPEUTICS INC | $0 | – | -4,259,653 | -100.0% | -0.32% | – |
| ACRS | Exit | ACLARIS THERAPEUTICS INC | $0 | – | -1,708,971 | -100.0% | -0.57% | – |
| QURE | Exit | UNIQURE NV | $0 | – | -865,767 | -100.0% | -0.72% | – |
| DCPH | Exit | DECIPHERA PHARMACEUTICALS IN | $0 | – | -1,363,201 | -100.0% | -0.86% | – |
| ARGX | Exit | ARGENX SEput | $0 | – | -100,000 | -100.0% | -1.53% | – |
| EXEL | Exit | EXELIXIS INC | $0 | – | -1,931,874 | -100.0% | -1.54% | – |
| SGEN | Exit | SEAGEN INCput | $0 | – | -217,800 | -100.0% | -1.81% | – |
| Exit | DICE THERAPEUTICS INC | $0 | – | -1,600,000 | -100.0% | -1.88% | – | |
| BIIB | Exit | BIOGEN INC | $0 | – | -200,000 | -100.0% | -2.28% | – |
| RETA | Exit | REATA PHARMACEUTICALS INCcl a | $0 | – | -729,000 | -100.0% | -2.72% | – |
| KDNY | Exit | CHINOOK THERAPEUTICS INC | $0 | – | -3,000,000 | -100.0% | -2.85% | – |
| ISEE | Exit | IVERIC BIO INC | $0 | – | -6,500,000 | -100.0% | -6.50% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2023-09-06
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| JAZZ PHARMACEUTICALS PLC | 8 | Q3 2023 | 7.2% |
| TRAVERE THERAPEUTICS INC | 8 | Q3 2023 | 5.7% |
| IMMUNOVANT INC | 8 | Q3 2023 | 7.2% |
| BICYCLE THERAPEUTICS PLC | 8 | Q3 2023 | 5.2% |
| BEAM THERAPEUTICS INC | 8 | Q3 2023 | 3.9% |
| 4D MOLECULAR THERAPEUTICS IN | 8 | Q3 2023 | 2.9% |
| REPARE THERAPEUTICS INC | 8 | Q3 2023 | 3.1% |
| VIRIDIAN THERAPEUTICS INC | 8 | Q3 2023 | 2.2% |
| DYNE THERAPEUTICS INC | 8 | Q3 2023 | 2.2% |
| SILENCE THERAPEUTICS PLC | 8 | Q3 2023 | 1.6% |
View Deep Track Capital, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Orchard Therapeutics plc | March 20, 2023 | 19,125,150 | 10.0% |
| ARDELYX, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| ASSEMBLY BIOSCIENCES, INC. | February 14, 2023 | 1,833,437 | 3.8% |
| Aurinia Pharmaceuticals Inc. | February 14, 2023 | 324,238 | 0.2% |
| CHINOOK THERAPEUTICS, INC. | February 14, 2023 | 3,000,000 | 4.7% |
| Forma Therapeutics Holdings, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Global Blood Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| HOOKIPA Pharma Inc. | February 14, 2023 | 1,240,369 | 2.4% |
| KalVista Pharmaceuticals, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Keros Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
View Deep Track Capital, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-26 |
| SC 13G | 2024-04-26 |
| SC 13G/A | 2024-04-22 |
| SC 13G | 2024-04-12 |
| SC 13G | 2024-04-05 |
| SC 13G | 2024-03-22 |
| SC 13G | 2024-03-22 |
| SC 13G | 2024-03-22 |
| SC 13G | 2024-03-15 |
| 3 | 2024-03-14 |
View Deep Track Capital, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.